查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829328

2025年全球乾粉吸入器市場報告

Dry Powder Inhaler Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，乾粉吸入器市場穩定成長，從2024年的212.5億美元增加到2025年的221.8億美元，複合年成長率為4.4%。這段歷史時期的成長可歸因於對永續建築材料、文化保護和遺產修復的重新關注、綠色建築實踐的興起、本地採購和社區參與，以及監管支持和建築規範的完善。

預計未來幾年乾粉吸入器市場規模將穩定成長，到2029年將達到268.2億美元，複合年成長率為4.9%。預測期內的成長可歸因於對永續性的持續重視、全球都市化趨勢、製造流程的進步、政府激勵措施和政策以及全球經濟因素。預測期內的主要趨勢包括研發力度加大、對傳統建築技術的重新關注、材料技術的進步、建築和設計趨勢以及對永續建築的監管支持。

乾粉吸入器 (DPI) 是醫療設備，旨在將藥物以乾粉形式直接輸送至肺部。它們主要用於治療氣喘和慢性阻塞性肺病(COPD) 等呼吸系統疾病。為了有效使用 DPI，使用者必須快速深吸，以確保藥物到達肺部。

乾粉吸入器主要分為單劑量吸入器和多劑量吸入器。單劑量吸入器將藥物以乾粉直接輸送至肺部。這類設備有手動和電子兩種形式，用於治療氣喘、慢性阻塞性肺病和囊腫纖維化等疾病。這類設備的終端使用者多種多樣，包括醫院、診所、家庭護理機構和門診手術中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供乾粉吸入器市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的乾粉吸入器細分市場、市場趨勢和商機，以及您在乾粉吸入器行業取得成功所需的數據。本乾粉吸入器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年4.9%的預測成長率比我們先前對該市場的預測略有下降，下降了0.1%。下降的主要原因是美國與其他國家之間的關稅影響。這可能會透過對來自英國和英國等主要地區的精密劑量計數器和呼吸驅動分散裝置徵收關稅直接影響美國，從而可能損害呼吸系統藥物輸送，並增加慢性阻塞性肺病(COPD) 和氣喘的治療成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，影響可能會更加廣泛。

呼吸系統疾病的日益流行預計將在未來幾年推動乾粉吸入器市場的成長。呼吸系統疾病涵蓋了影響呼吸系統的多種疾病，包括各種肺部疾病。乾粉吸入器透過將藥物直接輸送到最有效的肺部，在治療氣喘、慢性阻塞性肺病和囊腫纖維化等呼吸系統疾病方面發揮關鍵作用。這種方法為傳統的呼吸系統疾病藥物傳遞技術提供了一個很有前景的替代方案。例如，根據 2023 年 12 月發表在美國醫學會醫學雜誌 JAMA Network Open 上的一項研究，到 2050 年，全球慢性阻塞性肺病(COPD) 負擔預計將達到近 6 億例，患病率將增加 23%。值得注意的是，女性病例預計將增加 47.1%，而男性病例預計僅增加 9.4%。此外，這些病例大多發生在中低收入地區，預計到 2050 年，這些地區的盛行率將是高所得地區的兩倍以上。因此，呼吸系統疾病盛行率的上升將極大地推動乾粉吸入器市場的擴張。

預計空氣污染水平的上升也將推動乾粉吸入器市場的成長。空氣污染以空氣中各種污染物的濃度來衡量，會導致呼吸問題。乾粉吸入器是緩解空氣污染物加劇的症狀和控制呼吸系統疾病的首選藥物傳遞方式。 2022年，美國環保署報告稱，美國排放到空氣中的污染物數量約為6,600萬噸。此外，2023年3月，IQAir報告稱，伊拉克是2022年污染第二嚴重的國家，PM2.5濃度為80.1 μg/m3，是世界衛生組織年度PM2.5指導值的16倍。因此，預計空氣污染水平的上升將推動乾粉吸入器市場的成長。

乾粉吸入器市場的關鍵參與者正專注於開發以毒蕈鹼拮抗劑為特色的創新產品，用於治療慢性阻塞性肺病(COPD)，同時擴大產品系列。毒蕈鹼拮抗劑是阻斷毒蕈鹼乙醯膽鹼受體的藥物，用於治療各種疾病，包括 COPD 和有機磷中毒。例如，2024 年 3 月，以開發和製造各種軟包裝解決方案而聞名的美國公司 Berry Global 在其 Pharma Pack 中推出了一種新型乾粉吸入器。此吸入器專為改善 COPD 和氣喘等呼吸系統疾病的藥物輸送而設計，為製藥公司提供可客製化的解決方案。

2024年8月，美國藥物輸送專家阿普塔製藥（Aptar Pharma）收購了Orbital Dry Powder Inhalers，收購金額未揭露。此次收購增強了阿普塔在呼吸系統藥物傳輸領域的能力，尤其是在氣喘和慢性阻塞性肺病（COPD）等疾病的治療方面。 Orbital Dry Powder Inhalers以其創新的設計而聞名，可增強藥物傳遞。此次收購符合阿普塔製藥擴大產品組合、鞏固其在呼吸治療市場地位的策略。 Orbital Dry Powder Inhalers在印度的製藥和醫療設備領域開展業務。

乾粉吸入器市場包括乾粉泡沫吸入器、思力華手持式吸入器、呼吸啟動式吸入器、旋轉吸入器、乾粉吸入器和旋轉式吸入器的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球乾粉吸入器：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球乾粉吸入器市場：成長率分析
  • 全球乾粉吸入器市場表現：規模與成長，2019-2024
  • 全球乾粉吸入器市場預測：規模與成長，2024-2029年，2034年
  • 全球乾粉吸入器：總目標市場（TAM）

第6章 市場細分

  • 全球乾粉吸入器市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量吸入器
  • 多劑量吸入器
  • 全球乾粉吸入器市場：按功能、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 手動吸入器
  • 數位操作吸入器
  • 全球乾粉吸入器市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 氣喘
  • 慢性阻塞性肺病（COPD）
  • 囊腫纖維化
  • 其他用途
  • 全球乾粉吸入器市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 居家照護環境
  • 門診手術中心
  • 其他最終用戶
  • 全球乾粉吸入器市場：按單一吸入器類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 膠囊吸入器
  • 乾粉吸入器
  • 全球乾粉吸入器市場：按多劑量吸入器細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 泡殼式吸入器
  • Rotaheler 吸入器

第7章 區域和國家分析

  • 全球乾粉吸入器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球乾粉吸入器市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 乾粉吸入器市場：競爭格局
  • 乾粉吸入器市場：公司簡介
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Viatris（Mylan NV）
  • Otsuka Pharmaceutical Co. Ltd
  • Sun Pharmaceutical Industries Limited
  • Catalent Inc.
  • Aptar Group Inc.
  • Chiesi Farmaceutici SpA
  • Recipharm AB
  • Cipla Limited
  • Lupin Limited
  • Orion Corporation
  • OPKO Health
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Beximco Pharmaceuticals Ltd
  • Sava Healthcare Ltd.
  • Hovione

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年乾粉吸入器市場：提供新機會的國家
  • 2029年乾粉吸入器市場：細分市場帶來新機會
  • 2029年乾粉吸入器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27950u

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown steadily in recent years. It will grow from $21.25 billion in 2024 to $22.18 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to renewed interest in sustainable building materials, cultural preservation and heritage restoration, rise in green building practices, local sourcing and community involvement, regulatory support and building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $26.82 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies, global economic factors. Major trends in the forecast period include increased research and development, renewed interest in traditional building techniques, advancements in material technology, architectural and design trends, regulatory support for sustainable construction.

The forecast of 4.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on precision dose counters and breath-actuated dispersion mechanisms, sourced from key regions such as Germany and the UK, which could lead to compromised respiratory drug delivery and higher costs for chronic obstructive pulmonary disease (COPD) and asthma management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of disorders affecting the respiratory system, including various lung diseases. Dry powder inhalers play a critical role in treating respiratory conditions such as asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, where it is most effective. This method serves as a promising alternative to traditional drug delivery techniques for respiratory issues. For example, a study published in December 2023 by JAMA Network Open, a medical journal of the American Medical Association, indicates that the global burden of chronic obstructive pulmonary disease (COPD) is projected to nearly reach 600 million cases worldwide by 2050, reflecting a 23% increase in prevalence. Notably, cases among females are expected to surge by 47.1%, while male cases are projected to rise by only 9.4%. Additionally, the majority of these cases are expected to occur in low- and middle-income regions, where the prevalence is anticipated to be more than double that of high-income areas by 2050. Consequently, the growing prevalence of respiratory diseases will significantly drive the expansion of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

Key players in the dry powder inhaler market are focusing on developing innovative products featuring muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD) while also expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor, and they are used to manage various conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and manufacturing of diverse flexible packaging solutions, unveiled its new dry powder inhaler at Pharma Pack. This inhaler is specifically designed to improve drug delivery for respiratory conditions such as COPD and asthma, providing a customizable solution for pharmaceutical companies.

In August 2024, Aptar Pharma, a US-based specialist in drug delivery, acquired the Orbital Dry Powder Inhaler for an undisclosed sum. This acquisition strengthens Aptar's capabilities in respiratory drug delivery, especially for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). The Orbital Dry Powder Inhaler is noted for its innovative design, which enhances medication delivery. This acquisition aligns with Aptar Pharma's strategy to expand its product offerings and reinforce its position in the respiratory treatment market. The Orbital DPI operates within the pharmaceutical and medical device sectors in India.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
  • 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Single-Dose Inhalers: Capsule-Based Inhalers; Diskus-Based Inhalers
  • 2) By Multi-Dose Inhalers: Blister-Based Inhalers; Rotahaler-Based Inhalers
  • Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH; Viatris (Mylan N.V); Otsuka Pharmaceutical Co. Ltd; Sun Pharmaceutical Industries Limited; Catalent Inc.; Aptar Group Inc.; Chiesi Farmaceutici S.p.A.; Recipharm AB; Cipla Limited; Lupin Limited; Orion Corporation; OPKO Health; Zhejiang Hisun Pharmaceutical Co Ltd; Beximco Pharmaceuticals Ltd; Sava Healthcare Ltd.; Hovione; Elpen S.A.; MannKind Corporation; Meda Pharmaceuticals; Presspart Manufacturing Ltd; SMB Laboratories SA; Teva Pharmaceutical Industries Limited; Pharmaxis Ltd.; Iconovo AB; SRS Pharmaceuticals Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Dry Powder Inhaler Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Dry Powder Inhaler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Dry Powder Inhaler Market Growth Rate Analysis
  • 5.4. Global Dry Powder Inhaler Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Dry Powder Inhaler Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Dry Powder Inhaler Total Addressable Market (TAM)

6. Dry Powder Inhaler Market Segmentation

  • 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Other Applications
  • 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.5. Global Dry Powder Inhaler Market, Sub-Segmentation Of Single-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Capsule-Based Inhalers
  • Diskus-Based Inhalers
  • 6.6. Global Dry Powder Inhaler Market, Sub-Segmentation Of Multi-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blister-Based Inhalers
  • Rotahaler-Based Inhalers

7. Dry Powder Inhaler Market Regional And Country Analysis

  • 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

  • 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Powder Inhaler Market

  • 9.1. China Dry Powder Inhaler Market Overview
  • 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Powder Inhaler Market

  • 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Powder Inhaler Market

  • 11.1. Japan Dry Powder Inhaler Market Overview
  • 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Powder Inhaler Market

  • 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Powder Inhaler Market

  • 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Powder Inhaler Market

  • 14.1. South Korea Dry Powder Inhaler Market Overview
  • 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Powder Inhaler Market

  • 15.1. Western Europe Dry Powder Inhaler Market Overview
  • 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Powder Inhaler Market

  • 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Powder Inhaler Market

  • 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Powder Inhaler Market

  • 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Powder Inhaler Market

  • 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Powder Inhaler Market

  • 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

  • 21.1. Eastern Europe Dry Powder Inhaler Market Overview
  • 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Powder Inhaler Market

  • 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Powder Inhaler Market

  • 23.1. North America Dry Powder Inhaler Market Overview
  • 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Powder Inhaler Market

  • 24.1. USA Dry Powder Inhaler Market Overview
  • 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Powder Inhaler Market

  • 25.1. Canada Dry Powder Inhaler Market Overview
  • 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Powder Inhaler Market

  • 26.1. South America Dry Powder Inhaler Market Overview
  • 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Powder Inhaler Market

  • 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Powder Inhaler Market

  • 28.1. Middle East Dry Powder Inhaler Market Overview
  • 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Powder Inhaler Market

  • 29.1. Africa Dry Powder Inhaler Market Overview
  • 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

  • 30.1. Dry Powder Inhaler Market Competitive Landscape
  • 30.2. Dry Powder Inhaler Market Company Profiles
    • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Dry Powder Inhaler Market Other Major And Innovative Companies

  • 31.1. Viatris (Mylan N.V)
  • 31.2. Otsuka Pharmaceutical Co. Ltd
  • 31.3. Sun Pharmaceutical Industries Limited
  • 31.4. Catalent Inc.
  • 31.5. Aptar Group Inc.
  • 31.6. Chiesi Farmaceutici S.p.A.
  • 31.7. Recipharm AB
  • 31.8. Cipla Limited
  • 31.9. Lupin Limited
  • 31.10. Orion Corporation
  • 31.11. OPKO Health
  • 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
  • 31.13. Beximco Pharmaceuticals Ltd
  • 31.14. Sava Healthcare Ltd.
  • 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

34. Recent Developments In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market High Potential Countries, Segments and Strategies

  • 35.1 Dry Powder Inhaler Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Dry Powder Inhaler Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Dry Powder Inhaler Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer